InspireMD (NSPR) Reports In-Line Q2 EPS
InspireMD (NYSE: NSPR) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05).
For earnings history and earnings-related data on InspireMD (NSPR) click here.
InspireMD (NYSE: NSPR) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05).
For earnings history and earnings-related data on InspireMD (NSPR) click here.